Melanoma – Health

NICE clears Pierre Fabre's targeted melanoma combo to take on Novartis, Roche drugs

Thanks to new guidance from England’s drug cost watchdog, Novartis and Roche will be getting some fresh targeted melanoma competition from French pharma lab Pierre Fabre. In guidance published Friday, England’s National Institute for Health and Care Excellence signed off on Pierre Fabre’s combo of Braftovi and Mektovi to treat adult patients with unresectable or metastatic BRAF V600 mutation-positive melanoma.… Read More »

Melanoma death rates are rising in men but static or falling in women

The rate of men dying from malignant melanoma has risen in populations around the world, while in some countries the rates are steady or falling for women, according to research presented at the 2018 NCRI Cancer Conference. Researchers studied worldwide data on deaths gathered by the World Health Organisation, focusing on 33 countries with the… Read More »